Clinical Trials Browser

Interventional × Neuroma, Acoustic × Clear all

NCT07267910 2026-05-27

VESTI

Phase NA Not yet recruiting

Neuroma, Acoustic, Otorhinolaryngologic Diseases, Vestibular Diseases, Vestibular Neuronitis

NCT07479446 2026-05-22

Oliceridine Versus Sufentanil for Postoperative Nausea in Cerebellopontine Angle Surgery

Phase NA Recruiting

Neuroma, Acoustic, Postoperative Nausea and Vomiting

NCT03795675 2026-05-13

CI Following VS Removal or Labyrinthectomy

Phase NA Active not recruiting

Meniere Disease, Neuroma, Acoustic

NCT04374305 2026-05-06

INTUITT-NF2

Phase 2 Recruiting

Ependymoma, Meningioma, Neuroma, Acoustic, Neurofibromatosis 2

NCT06517888 2026-04-06

Anti-VEGF Gene Therapy Trial for Vestibular Schwannoma

Phase 1/2 Recruiting

Neuroma, Acoustic, Hearing Loss

NCT07493447 2026-03-25

Pilot Study Evaluating Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Intracranial Lesions During Neurosurgical Procedures

Phase EARLY_PHASE1 Not yet recruiting

Brain Neoplasms, Glioblastoma, Meningioma, Neoplasms, Neuroma, Acoustic, Pituitary Neoplasms

NCT05702749 2026-03-24

VS PREHAB

Phase NA Recruiting

Neuroma, Acoustic

NCT07364955 2026-01-23

Vestibular Rehabilitation Protocol in Unilateral Vestibular Schwannoma

Phase NA Recruiting

Neuroma, Acoustic

NCT06163664 2026-01-13

Role of ChatGPT in Vestibular Schwannoma Management

Phase NA Withdrawn

Neuroma, Acoustic

NCT06322342 2025-12-26

Phase 2 Ascending Dose Safety and Efficacy Study of RVP-001, a Manganese-based MRI Contrast Agent

Phase 2 Completed

Neuroinflammatory Diseases, Brain Neoplasms, Glioma, Meningioma, Multiple Sclerosis, Neoplasms, Neurilemmoma, Neurofibroma, Neuroma, Acoustic, Central Nervous System Neoplasms

NCT07305285 2025-12-26

Roy Adaptation Model Improves Mood and QOL After Giant Acoustic Neuroma

Phase NA Completed

Facial Paralysis, Neuroma, Acoustic

NCT03261726 2025-12-19

Maintaining Cochlear Patency After VIIIth Nerve Surgery

Phase NA Withdrawn

Neuroma, Acoustic, Hearing Loss, Unilateral

NCT03079999 2025-12-18

Study of Aspirin in Patients With Vestibular Schwannoma

Phase 2 Active not recruiting

Neuroma, Acoustic, Neurofibromatosis 2

NCT02282917 2025-12-05

Exploratory Evaluation of AR-42 Histone Deacetylase Inhibitor in the Treatment of Vestibular Schwannoma and Meningioma

Phase EARLY_PHASE1 Terminated

7 enrolled 19 charts

Meningioma, Neurilemmoma, Neuroma, Acoustic, Neurofibromatosis 2

NCT05622344 2025-11-10

SWAN

Phase NA Recruiting

Motion Sickness, Neuroma, Acoustic, Vestibular Diseases, Space Motion Sickness

NCT01199978 2025-10-01

Hearing Outcomes Using Fractionated Proton Radiation Therapy for Vestibular Schwannoma

Phase 2 Active not recruiting

Neuroma, Acoustic

NCT04057976 2025-09-12

Use of DTT to Define Facial Nerve Position in Vestibular Schwannomas

Phase NA Completed

Neuroma, Acoustic

NCT07130851 2025-08-19

Mapping of Vestibular Centers Activation Using fMRI in Patients With Vestibular Schwannoma

Phase NA Active not recruiting

Neuroma, Acoustic

NCT07116811 2025-08-12

SAF-NRVS

Phase 3 Not yet recruiting

Facial Paralysis, Neuroma, Acoustic, Bell Palsy

NCT04743310 2025-06-13

Fluorescence Detection of Adult Primary Central Nervous System Tumors With Tozuleristide and the Canvas System

Phase 2 Completed

Astrocytoma, Brain Neoplasms, Craniopharyngioma, Ependymoma, Glioblastoma, Glioma, Medulloblastoma, Meningioma, Neoplasms, Germ Cell and Embryonal, Neuroma, Acoustic, Pinealoma, Spinal Cord Neoplasms, Central Nervous System Neoplasms

NCT06660082 2025-05-16

KINE HIT

Phase NA Recruiting

Neuroma, Acoustic

NCT03095248 2025-04-22

SEL-TH-1601

Phase 2 Terminated

10 enrolled 9 charts

Ependymoma, Glioma, Meningioma, Neuroma, Acoustic, Neurofibromatosis 2

NCT04196933 2025-04-16

Analysis of Vestibular Compensation Following Clinical Intervention for Vestibular Schwannoma

Phase NA Withdrawn

Dizziness, Migraine Disorders, Motion Sickness, Neuroma, Acoustic, Vestibular Diseases

NCT01083966 2025-04-09

Super-Selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Vestibular Schwannoma

Phase 1 Suspended

Brain Neoplasms, Neurilemmoma, Neuroma, Neuroma, Acoustic

NCT02249572 2025-04-02

V-REX

Phase NA Completed

Neuroma, Acoustic

NCT04594057 2025-03-19

Longitudinal Recovery of Laboratory, Clinical, and Community-Based Measures of Head and Trunk Control in People With Acquired Vestibulopathy

Phase NA Terminated

Neuroma, Acoustic, Vestibular Diseases

NCT06112509 2024-09-19

EVERS

Phase NA Recruiting

Neurilemmoma, Neuroma, Acoustic

NCT06572475 2024-08-27

UMIC

Phase NA Recruiting

Astrocytoma, Neuroma, Acoustic

NCT04859335 2024-08-02

EQUI-GAMMA

Phase NA Recruiting

Dizziness, Neuroma, Acoustic

NCT04241679 2024-04-25

ANTS

Phase NA Completed

Vestibulocochlear Nerve Diseases, Hearing Loss, Sensorineural, Neuroma, Acoustic, Retrocochlear Diseases, Skull Base Neoplasms, Vestibulocochlear Nerve Injuries

NCT01938677 2024-04-18

Gamma Knife Radiosurgery vs Initial Conservative Treatment for Vestibular Schwannoma Patients With Preserved Hearing, a Prospective Randomized Study

Phase NA Completed

Neuroma, Acoustic

NCT01345136 2024-02-13

Study of RAD001 for Treatment of NF2-related Vestibular Schwannoma

Phase 2 Terminated

Neuroma, Acoustic, Neurofibromatosis 2

NCT04801953 2023-10-19

Nimodipine in Vestibular Schwanommas

Phase 2 Unknown

Neuroma, Acoustic

NCT05116878 2023-09-08

EFFORTS

Phase NA Terminated

Neuroma, Acoustic

NCT04351373 2023-08-01

Microscopic Fluorescence-guided Vestibular Schwannoma Resection Using Fluorescein Sodium and YELLOW 560

Phase 2 Completed

12 enrolled 11 charts

Neuroma, Acoustic

NCT03581331 2023-07-14

SVorthoptie

Phase NA Completed

Neuroma, Acoustic, Vision Disorders

NCT03958006 2023-04-20

Simultaneous Cochlear Implantation During Translabyrinthine Resection of Vestibular Schwannoma

Phase NA Completed

Neuroma, Acoustic

NCT04890132 2023-03-16

Vestibular Precision: Physiology & Pathophysiology

Phase NA Unknown

Dizziness, Labyrinth Diseases, Neuroma, Acoustic, Vestibular Diseases, Neurofibromatosis 2

NCT05248113 2022-12-01

Intraoperative Electrically-evoked ABRs in Patients Undergoing Vestibular Schwannoma Surgery

Phase NA Unknown

Deafness, Neuroma, Acoustic

NCT05567341 2022-10-05

RIC-VS

Phase NA Unknown

Neuroma, Acoustic

NCT04658836 2022-08-24

Triamcinolone Levels in Cochlear Perilymph, Lateral Canal and CSF

Phase 1 Completed

Neuroma, Acoustic

NCT04148534 2022-06-29

Compare the Operating Condition of Two Levels of Muscle Relaxation on Facial Nerve MEP Monitoring in CPA Surgery

Phase NA Completed

Neuroma, Acoustic

NCT03057678 2022-01-20

PPF

Phase NA Withdrawn

Neuroma, Acoustic

NCT02129647 2021-12-01

Study of Axitinib in Patients With Neurofibromatosis Type 2 and Progressive Vestibular Schwannomas

Phase 2 Completed

13 enrolled 7 charts

Neuroma, Acoustic, Neurofibromatosis 2

NCT02948790 2021-10-20

NeuriStim

Phase NA Completed

Hearing Loss, Sensorineural, Neuroma, Acoustic

NCT02934256 2021-09-09

Icotinib

Phase 2 Completed

Neuroma, Acoustic, Neurofibromatosis 2

NCT02055859 2021-02-21

ACOUNEU

Phase NA Unknown

Neuroma, Acoustic

NCT01125046 2021-01-22

Bevacizumab in Treating Patients With Recurrent or Progressive Meningiomas

Phase 2 Completed

50 enrolled 13 charts

Brain Neoplasms, Ependymoma, Meningioma, Neurofibromatosis 1, Neuroma, Acoustic, Neurofibromatosis 2

NCT00863122 2021-01-12

Concentration and Activity of Lapatinib in Vestibular Schwannomas

Phase EARLY_PHASE1 Completed

26 enrolled 9 charts

Neuroma, Acoustic, Neurofibromatosis 2

NCT02379754 2020-09-11

Gentamicin Treatment Prior to Schwannoma Surgery - Residual Function

Phase 4 Withdrawn

Neuroma, Acoustic